nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00212	CcSEcCtD
Milnacipran—Hypersensitivity—Progesterone—uterine cancer	0.00211	0.00211	CcSEcCtD
Milnacipran—Bladder pain—Epirubicin—uterine cancer	0.00208	0.00208	CcSEcCtD
Milnacipran—Cystitis noninfective—Doxorubicin—uterine cancer	0.00208	0.00208	CcSEcCtD
Milnacipran—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00206	CcSEcCtD
Milnacipran—Cystitis—Doxorubicin—uterine cancer	0.00206	0.00206	CcSEcCtD
Milnacipran—Asthenia—Progesterone—uterine cancer	0.00205	0.00205	CcSEcCtD
Milnacipran—Hypoaesthesia—Etoposide—uterine cancer	0.00205	0.00205	CcSEcCtD
Milnacipran—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00205	CcSEcCtD
Milnacipran—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00205	CcSEcCtD
Milnacipran—Urinary tract disorder—Etoposide—uterine cancer	0.00204	0.00204	CcSEcCtD
Milnacipran—Pruritus—Progesterone—uterine cancer	0.00203	0.00203	CcSEcCtD
Milnacipran—Urethral disorder—Etoposide—uterine cancer	0.00202	0.00202	CcSEcCtD
Milnacipran—Infection—Dactinomycin—uterine cancer	0.00201	0.00201	CcSEcCtD
Milnacipran—Thrombocytopenia—Dactinomycin—uterine cancer	0.00198	0.00198	CcSEcCtD
Milnacipran—Dry eye—Doxorubicin—uterine cancer	0.00197	0.00197	CcSEcCtD
Milnacipran—Diarrhoea—Progesterone—uterine cancer	0.00196	0.00196	CcSEcCtD
Milnacipran—Erythema multiforme—Etoposide—uterine cancer	0.00195	0.00195	CcSEcCtD
Milnacipran—Anorexia—Dactinomycin—uterine cancer	0.00193	0.00193	CcSEcCtD
Milnacipran—Eye disorder—Etoposide—uterine cancer	0.00193	0.00193	CcSEcCtD
Milnacipran—Bladder pain—Doxorubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Milnacipran—Cardiac disorder—Etoposide—uterine cancer	0.00191	0.00191	CcSEcCtD
Milnacipran—Flushing—Etoposide—uterine cancer	0.00191	0.00191	CcSEcCtD
Milnacipran—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00191	CcSEcCtD
Milnacipran—Dizziness—Progesterone—uterine cancer	0.00189	0.00189	CcSEcCtD
Milnacipran—Angiopathy—Etoposide—uterine cancer	0.00187	0.00187	CcSEcCtD
Milnacipran—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00186	CcSEcCtD
Milnacipran—Mediastinal disorder—Etoposide—uterine cancer	0.00186	0.00186	CcSEcCtD
Milnacipran—Chills—Etoposide—uterine cancer	0.00185	0.00185	CcSEcCtD
Milnacipran—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00184	CcSEcCtD
Milnacipran—Vomiting—Progesterone—uterine cancer	0.00182	0.00182	CcSEcCtD
Milnacipran—Renal failure acute—Epirubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Milnacipran—Rash—Progesterone—uterine cancer	0.00181	0.00181	CcSEcCtD
Milnacipran—Dermatitis—Progesterone—uterine cancer	0.0018	0.0018	CcSEcCtD
Milnacipran—Headache—Progesterone—uterine cancer	0.00179	0.00179	CcSEcCtD
Milnacipran—Hot flush—Epirubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Milnacipran—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00177	CcSEcCtD
Milnacipran—Menopausal symptoms—Epirubicin—uterine cancer	0.00177	0.00177	CcSEcCtD
Milnacipran—Decreased appetite—Dactinomycin—uterine cancer	0.00176	0.00176	CcSEcCtD
Milnacipran—Dysgeusia—Etoposide—uterine cancer	0.00176	0.00176	CcSEcCtD
Milnacipran—Fatigue—Dactinomycin—uterine cancer	0.00174	0.00174	CcSEcCtD
Milnacipran—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00172	CcSEcCtD
Milnacipran—Nausea—Progesterone—uterine cancer	0.0017	0.0017	CcSEcCtD
Milnacipran—Hyponatraemia—Epirubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Milnacipran—Renal failure acute—Doxorubicin—uterine cancer	0.00167	0.00167	CcSEcCtD
Milnacipran—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00165	0.00165	CcSEcCtD
Milnacipran—Hot flush—Doxorubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Milnacipran—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00165	CcSEcCtD
Milnacipran—Migraine—Epirubicin—uterine cancer	0.00164	0.00164	CcSEcCtD
Milnacipran—Menopausal symptoms—Doxorubicin—uterine cancer	0.00164	0.00164	CcSEcCtD
Milnacipran—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00164	CcSEcCtD
Milnacipran—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00163	CcSEcCtD
Milnacipran—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00163	CcSEcCtD
Milnacipran—Leukopenia—Etoposide—uterine cancer	0.00161	0.00161	CcSEcCtD
Milnacipran—Abdominal pain—Dactinomycin—uterine cancer	0.0016	0.0016	CcSEcCtD
Milnacipran—Body temperature increased—Dactinomycin—uterine cancer	0.0016	0.0016	CcSEcCtD
Milnacipran—Loss of consciousness—Etoposide—uterine cancer	0.00158	0.00158	CcSEcCtD
Milnacipran—Convulsion—Etoposide—uterine cancer	0.00155	0.00155	CcSEcCtD
Milnacipran—Hyponatraemia—Doxorubicin—uterine cancer	0.00155	0.00155	CcSEcCtD
Milnacipran—Hypertension—Etoposide—uterine cancer	0.00155	0.00155	CcSEcCtD
Milnacipran—Liver function test abnormal—Epirubicin—uterine cancer	0.00154	0.00154	CcSEcCtD
Milnacipran—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00154	CcSEcCtD
Milnacipran—Dry skin—Epirubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Milnacipran—Chest pain—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Milnacipran—Migraine—Doxorubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00152	0.00152	CcSEcCtD
Milnacipran—Breast disorder—Epirubicin—uterine cancer	0.00151	0.00151	CcSEcCtD
Milnacipran—Hypersensitivity—Dactinomycin—uterine cancer	0.00149	0.00149	CcSEcCtD
Milnacipran—Infection—Etoposide—uterine cancer	0.00145	0.00145	CcSEcCtD
Milnacipran—Abdominal distension—Epirubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Milnacipran—Asthenia—Dactinomycin—uterine cancer	0.00145	0.00145	CcSEcCtD
Milnacipran—Thrombocytopenia—Etoposide—uterine cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Tachycardia—Etoposide—uterine cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Liver function test abnormal—Doxorubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Milnacipran—Skin disorder—Etoposide—uterine cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Dry skin—Doxorubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Hyperhidrosis—Etoposide—uterine cancer	0.00142	0.00142	CcSEcCtD
Milnacipran—Angina pectoris—Epirubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Milnacipran—Breast disorder—Doxorubicin—uterine cancer	0.0014	0.0014	CcSEcCtD
Milnacipran—Anorexia—Etoposide—uterine cancer	0.0014	0.0014	CcSEcCtD
Milnacipran—Diarrhoea—Dactinomycin—uterine cancer	0.00138	0.00138	CcSEcCtD
Milnacipran—Hypotension—Etoposide—uterine cancer	0.00137	0.00137	CcSEcCtD
Milnacipran—Dysuria—Epirubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Neutropenia—Epirubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Milnacipran—Abdominal distension—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Milnacipran—Pollakiuria—Epirubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
Milnacipran—Paraesthesia—Etoposide—uterine cancer	0.00132	0.00132	CcSEcCtD
Milnacipran—Weight decreased—Epirubicin—uterine cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Dyspnoea—Etoposide—uterine cancer	0.00131	0.00131	CcSEcCtD
Milnacipran—Somnolence—Etoposide—uterine cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Angina pectoris—Doxorubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Milnacipran—Vomiting—Dactinomycin—uterine cancer	0.00129	0.00129	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Milnacipran—Rash—Dactinomycin—uterine cancer	0.00128	0.00128	CcSEcCtD
Milnacipran—Decreased appetite—Etoposide—uterine cancer	0.00127	0.00127	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Etoposide—uterine cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Fatigue—Etoposide—uterine cancer	0.00126	0.00126	CcSEcCtD
Milnacipran—Constipation—Etoposide—uterine cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Urinary tract infection—Epirubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Dysuria—Doxorubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Neutropenia—Doxorubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00124	0.00124	CcSEcCtD
Milnacipran—Pollakiuria—Doxorubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Haematuria—Epirubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Milnacipran—Hepatobiliary disease—Epirubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Milnacipran—Weight decreased—Doxorubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Milnacipran—Nausea—Dactinomycin—uterine cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Gastrointestinal pain—Etoposide—uterine cancer	0.0012	0.0012	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Milnacipran—Urticaria—Etoposide—uterine cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Abdominal pain—Etoposide—uterine cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Body temperature increased—Etoposide—uterine cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Urinary tract infection—Doxorubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Hepatitis—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Milnacipran—Hypoaesthesia—Epirubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Milnacipran—Urinary tract disorder—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Oedema peripheral—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Haematuria—Doxorubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Connective tissue disorder—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Milnacipran—Urethral disorder—Epirubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Milnacipran—Erythema multiforme—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Milnacipran—Eye disorder—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Hypersensitivity—Etoposide—uterine cancer	0.00108	0.00108	CcSEcCtD
Milnacipran—Cardiac disorder—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Flushing—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Hepatitis—Doxorubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Milnacipran—Hypoaesthesia—Doxorubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Urinary tract disorder—Doxorubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Milnacipran—Oedema peripheral—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Asthenia—Etoposide—uterine cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Connective tissue disorder—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Angiopathy—Epirubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Urethral disorder—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Milnacipran—Mediastinal disorder—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Chills—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Pruritus—Etoposide—uterine cancer	0.00104	0.00104	CcSEcCtD
Milnacipran—Mental disorder—Epirubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Erythema multiforme—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Malnutrition—Epirubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Milnacipran—Diarrhoea—Etoposide—uterine cancer	0.001	0.001	CcSEcCtD
Milnacipran—Eye disorder—Doxorubicin—uterine cancer	0.000999	0.000999	CcSEcCtD
Milnacipran—Flushing—Doxorubicin—uterine cancer	0.000992	0.000992	CcSEcCtD
Milnacipran—Cardiac disorder—Doxorubicin—uterine cancer	0.000992	0.000992	CcSEcCtD
Milnacipran—Flatulence—Epirubicin—uterine cancer	0.000991	0.000991	CcSEcCtD
Milnacipran—Tension—Epirubicin—uterine cancer	0.000987	0.000987	CcSEcCtD
Milnacipran—Dysgeusia—Epirubicin—uterine cancer	0.000985	0.000985	CcSEcCtD
Milnacipran—Angiopathy—Doxorubicin—uterine cancer	0.00097	0.00097	CcSEcCtD
Milnacipran—Dizziness—Etoposide—uterine cancer	0.000968	0.000968	CcSEcCtD
Milnacipran—Mediastinal disorder—Doxorubicin—uterine cancer	0.000964	0.000964	CcSEcCtD
Milnacipran—Chills—Doxorubicin—uterine cancer	0.000959	0.000959	CcSEcCtD
Milnacipran—Vision blurred—Epirubicin—uterine cancer	0.000948	0.000948	CcSEcCtD
Milnacipran—Mental disorder—Doxorubicin—uterine cancer	0.000937	0.000937	CcSEcCtD
Milnacipran—Vomiting—Etoposide—uterine cancer	0.000931	0.000931	CcSEcCtD
Milnacipran—Malnutrition—Doxorubicin—uterine cancer	0.000931	0.000931	CcSEcCtD
Milnacipran—Agitation—Epirubicin—uterine cancer	0.000924	0.000924	CcSEcCtD
Milnacipran—Rash—Etoposide—uterine cancer	0.000923	0.000923	CcSEcCtD
Milnacipran—Dermatitis—Etoposide—uterine cancer	0.000923	0.000923	CcSEcCtD
Milnacipran—Headache—Etoposide—uterine cancer	0.000917	0.000917	CcSEcCtD
Milnacipran—Flatulence—Doxorubicin—uterine cancer	0.000917	0.000917	CcSEcCtD
Milnacipran—Tension—Doxorubicin—uterine cancer	0.000913	0.000913	CcSEcCtD
Milnacipran—Dysgeusia—Doxorubicin—uterine cancer	0.000911	0.000911	CcSEcCtD
Milnacipran—Syncope—Epirubicin—uterine cancer	0.000902	0.000902	CcSEcCtD
Milnacipran—Leukopenia—Epirubicin—uterine cancer	0.0009	0.0009	CcSEcCtD
Milnacipran—Palpitations—Epirubicin—uterine cancer	0.000889	0.000889	CcSEcCtD
Milnacipran—Loss of consciousness—Epirubicin—uterine cancer	0.000884	0.000884	CcSEcCtD
Milnacipran—Vision blurred—Doxorubicin—uterine cancer	0.000877	0.000877	CcSEcCtD
Milnacipran—Convulsion—Epirubicin—uterine cancer	0.000872	0.000872	CcSEcCtD
Milnacipran—Nausea—Etoposide—uterine cancer	0.00087	0.00087	CcSEcCtD
Milnacipran—Hypertension—Epirubicin—uterine cancer	0.000868	0.000868	CcSEcCtD
Milnacipran—Chest pain—Epirubicin—uterine cancer	0.000856	0.000856	CcSEcCtD
Milnacipran—Agitation—Doxorubicin—uterine cancer	0.000855	0.000855	CcSEcCtD
Milnacipran—Anxiety—Epirubicin—uterine cancer	0.000853	0.000853	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00085	0.00085	CcSEcCtD
Milnacipran—Dry mouth—Epirubicin—uterine cancer	0.000838	0.000838	CcSEcCtD
Milnacipran—Syncope—Doxorubicin—uterine cancer	0.000835	0.000835	CcSEcCtD
Milnacipran—Leukopenia—Doxorubicin—uterine cancer	0.000833	0.000833	CcSEcCtD
Milnacipran—Palpitations—Doxorubicin—uterine cancer	0.000822	0.000822	CcSEcCtD
Milnacipran—Loss of consciousness—Doxorubicin—uterine cancer	0.000818	0.000818	CcSEcCtD
Milnacipran—Infection—Epirubicin—uterine cancer	0.000816	0.000816	CcSEcCtD
Milnacipran—Shock—Epirubicin—uterine cancer	0.000808	0.000808	CcSEcCtD
Milnacipran—Convulsion—Doxorubicin—uterine cancer	0.000806	0.000806	CcSEcCtD
Milnacipran—Nervous system disorder—Epirubicin—uterine cancer	0.000805	0.000805	CcSEcCtD
Milnacipran—Thrombocytopenia—Epirubicin—uterine cancer	0.000804	0.000804	CcSEcCtD
Milnacipran—Hypertension—Doxorubicin—uterine cancer	0.000804	0.000804	CcSEcCtD
Milnacipran—Tachycardia—Epirubicin—uterine cancer	0.000801	0.000801	CcSEcCtD
Milnacipran—Skin disorder—Epirubicin—uterine cancer	0.000797	0.000797	CcSEcCtD
Milnacipran—Hyperhidrosis—Epirubicin—uterine cancer	0.000794	0.000794	CcSEcCtD
Milnacipran—Chest pain—Doxorubicin—uterine cancer	0.000792	0.000792	CcSEcCtD
Milnacipran—Anxiety—Doxorubicin—uterine cancer	0.00079	0.00079	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000787	0.000787	CcSEcCtD
Milnacipran—Anorexia—Epirubicin—uterine cancer	0.000783	0.000783	CcSEcCtD
Milnacipran—Dry mouth—Doxorubicin—uterine cancer	0.000775	0.000775	CcSEcCtD
Milnacipran—Hypotension—Epirubicin—uterine cancer	0.000767	0.000767	CcSEcCtD
Milnacipran—Infection—Doxorubicin—uterine cancer	0.000755	0.000755	CcSEcCtD
Milnacipran—Shock—Doxorubicin—uterine cancer	0.000747	0.000747	CcSEcCtD
Milnacipran—Nervous system disorder—Doxorubicin—uterine cancer	0.000745	0.000745	CcSEcCtD
Milnacipran—Thrombocytopenia—Doxorubicin—uterine cancer	0.000744	0.000744	CcSEcCtD
Milnacipran—Insomnia—Epirubicin—uterine cancer	0.000742	0.000742	CcSEcCtD
Milnacipran—Tachycardia—Doxorubicin—uterine cancer	0.000741	0.000741	CcSEcCtD
Milnacipran—Skin disorder—Doxorubicin—uterine cancer	0.000738	0.000738	CcSEcCtD
Milnacipran—Paraesthesia—Epirubicin—uterine cancer	0.000737	0.000737	CcSEcCtD
Milnacipran—Hyperhidrosis—Doxorubicin—uterine cancer	0.000734	0.000734	CcSEcCtD
Milnacipran—Dyspnoea—Epirubicin—uterine cancer	0.000732	0.000732	CcSEcCtD
Milnacipran—Somnolence—Epirubicin—uterine cancer	0.00073	0.00073	CcSEcCtD
Milnacipran—Anorexia—Doxorubicin—uterine cancer	0.000724	0.000724	CcSEcCtD
Milnacipran—Dyspepsia—Epirubicin—uterine cancer	0.000723	0.000723	CcSEcCtD
Milnacipran—Decreased appetite—Epirubicin—uterine cancer	0.000714	0.000714	CcSEcCtD
Milnacipran—Hypotension—Doxorubicin—uterine cancer	0.00071	0.00071	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000709	0.000709	CcSEcCtD
Milnacipran—Fatigue—Epirubicin—uterine cancer	0.000708	0.000708	CcSEcCtD
Milnacipran—Constipation—Epirubicin—uterine cancer	0.000702	0.000702	CcSEcCtD
Milnacipran—Insomnia—Doxorubicin—uterine cancer	0.000687	0.000687	CcSEcCtD
Milnacipran—Paraesthesia—Doxorubicin—uterine cancer	0.000682	0.000682	CcSEcCtD
Milnacipran—Dyspnoea—Doxorubicin—uterine cancer	0.000677	0.000677	CcSEcCtD
Milnacipran—Somnolence—Doxorubicin—uterine cancer	0.000675	0.000675	CcSEcCtD
Milnacipran—Gastrointestinal pain—Epirubicin—uterine cancer	0.000671	0.000671	CcSEcCtD
Milnacipran—Dyspepsia—Doxorubicin—uterine cancer	0.000669	0.000669	CcSEcCtD
Milnacipran—Decreased appetite—Doxorubicin—uterine cancer	0.00066	0.00066	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000656	0.000656	CcSEcCtD
Milnacipran—Fatigue—Doxorubicin—uterine cancer	0.000655	0.000655	CcSEcCtD
Milnacipran—Urticaria—Epirubicin—uterine cancer	0.000652	0.000652	CcSEcCtD
Milnacipran—Constipation—Doxorubicin—uterine cancer	0.00065	0.00065	CcSEcCtD
Milnacipran—Abdominal pain—Epirubicin—uterine cancer	0.000649	0.000649	CcSEcCtD
Milnacipran—Body temperature increased—Epirubicin—uterine cancer	0.000649	0.000649	CcSEcCtD
Milnacipran—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000621	0.000621	CcSEcCtD
Milnacipran—Hypersensitivity—Epirubicin—uterine cancer	0.000605	0.000605	CcSEcCtD
Milnacipran—Urticaria—Doxorubicin—uterine cancer	0.000603	0.000603	CcSEcCtD
Milnacipran—Body temperature increased—Doxorubicin—uterine cancer	0.0006	0.0006	CcSEcCtD
Milnacipran—Abdominal pain—Doxorubicin—uterine cancer	0.0006	0.0006	CcSEcCtD
Milnacipran—Asthenia—Epirubicin—uterine cancer	0.000589	0.000589	CcSEcCtD
Milnacipran—Pruritus—Epirubicin—uterine cancer	0.000581	0.000581	CcSEcCtD
Milnacipran—Diarrhoea—Epirubicin—uterine cancer	0.000562	0.000562	CcSEcCtD
Milnacipran—Hypersensitivity—Doxorubicin—uterine cancer	0.00056	0.00056	CcSEcCtD
Milnacipran—Asthenia—Doxorubicin—uterine cancer	0.000545	0.000545	CcSEcCtD
Milnacipran—Dizziness—Epirubicin—uterine cancer	0.000543	0.000543	CcSEcCtD
Milnacipran—Pruritus—Doxorubicin—uterine cancer	0.000537	0.000537	CcSEcCtD
Milnacipran—Vomiting—Epirubicin—uterine cancer	0.000522	0.000522	CcSEcCtD
Milnacipran—Diarrhoea—Doxorubicin—uterine cancer	0.00052	0.00052	CcSEcCtD
Milnacipran—Rash—Epirubicin—uterine cancer	0.000518	0.000518	CcSEcCtD
Milnacipran—Dermatitis—Epirubicin—uterine cancer	0.000517	0.000517	CcSEcCtD
Milnacipran—Headache—Epirubicin—uterine cancer	0.000514	0.000514	CcSEcCtD
Milnacipran—Dizziness—Doxorubicin—uterine cancer	0.000502	0.000502	CcSEcCtD
Milnacipran—Nausea—Epirubicin—uterine cancer	0.000488	0.000488	CcSEcCtD
Milnacipran—Vomiting—Doxorubicin—uterine cancer	0.000483	0.000483	CcSEcCtD
Milnacipran—Rash—Doxorubicin—uterine cancer	0.000479	0.000479	CcSEcCtD
Milnacipran—Dermatitis—Doxorubicin—uterine cancer	0.000478	0.000478	CcSEcCtD
Milnacipran—Headache—Doxorubicin—uterine cancer	0.000476	0.000476	CcSEcCtD
Milnacipran—Nausea—Doxorubicin—uterine cancer	0.000451	0.000451	CcSEcCtD
